{
  "id": "5c6ffc5b7c78d69471000057",
  "type": "summary",
  "question": "What is the role of metalloproteinase-17 (ADAM17) in NK cells?",
  "ideal_answer": "The metalloproteinase-17 (ADAM17) is involved in CD16A cleavage and acts as a regulatory checkpoint in NK cells",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23625205",
    "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
    "http://www.ncbi.nlm.nih.gov/pubmed/17510296",
    "http://www.ncbi.nlm.nih.gov/pubmed/30009514",
    "http://www.ncbi.nlm.nih.gov/pubmed/25816339",
    "http://www.ncbi.nlm.nih.gov/pubmed/19395875",
    "http://www.ncbi.nlm.nih.gov/pubmed/21480393",
    "http://www.ncbi.nlm.nih.gov/pubmed/27077118",
    "http://www.ncbi.nlm.nih.gov/pubmed/20871631",
    "http://www.ncbi.nlm.nih.gov/pubmed/29978334"
  ],
  "snippets": [
    {
      "text": " To address this concern, bispecific or trispecific engagers that target NK cells to the tumour and an ADAM17 inhibitor that prevents CD16 shedding after NK cell activation are being tested",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30009514",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ese findings support ADAM17 as a dynamic inhibitory checkpoint of the potent activating receptor CD16A, which can be targeted by MEDI3622 to potentially increase the efficacy of anti-tumor therapeutic antibodie",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29978334",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our findings provide further characterization of CD16 cleavage by ADAM17 and they demonstrate that a non-cleavable version of CD16a can be expressed in engineered NK cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25816339",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CD16a and CD16b are IgG Fc receptors expressed by human natural killer (NK) cells and neutrophils, respectively. Both CD16 isoforms undergo a rapid down-regulation in expression by ADAM17-mediated proteolytic cleavage upon cell activation by various stimuli.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25816339",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Bispecific or trispecific killer engagers that target CD16 on NK cells to enhance recognition of tumor antigens, and desintegrin and metalloproteinase 17 (ADAM17) inhibition that prevents CD16 shedding after NK-cell activation should promote enhanced killing of cancer with specificity",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages.TNF-alpha and its receptors TNFRI and TNFRII are cleaved from the surface of leukocytes by a proteolytic process referred to as ectodomain shedding. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17510296",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A disintegrin and metalloproteinase-17 (ADAM17) is involved in proteolytic ectodomain shedding of several membrane-bound growth factors and cytokines.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21480393",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A disintegrin and metalloproteinase-17 (ADAM17) is involved in proteolytic ectodomain shedding of several membrane-bound growth factors and cytokines.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19395875",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A disintegrin and metalloproteinase-17 (ADAM17) is a member of the metalloproteinase superfamily and involved in the cleavage of ectodomain of many transmembrane proteins.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23625205",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Bispecific or trispecific killer engagers that target CD16 on NK cells to enhance recognition of tumor antigens, and desintegrin and metalloproteinase 17 (ADAM17) inhibition that prevents CD16 shedding after NK-cell activation should promote enhanced killing of cancer with specificity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ADAM17 (a disintegrin and metalloproteinase 17, also referred to as TNF\u03b1 converting enzyme or TACE) is a cell-surface metalloproteinase that regulates signaling via the epidermal growth factor receptor (EGFR) and has important roles in diseases such as cancer and rheumatoid arthritis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20871631",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we demonstrate that a disintegrin and metalloproteinase-17 (ADAM17), a main sheddase for tumor necrosis factor (TNF)-\u03b1, is essential for defensive epithelial properties against UC by promoting epithelial cell growth and goblet cell differentiation in mouse and human.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27077118",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}